Editas Medicine Inc buy Slaandjivaa
Start price
22.01.18
/
50%
€30.80
Target price
23.07.18
€34.28
Performance (%)
6.15%
End price
23.07.18
€32.70
Summary
This prediction ended on 23.07.18 with a price of €32.70. With a performance of 6.15%, the BUY prediction by Slaandjivaa for Editas Medicine Inc closed with a slight gain. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Editas Medicine Inc | 4.600% | 4.600% | 19.304% | -75.981% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by Slaandjivaa for this prediction
In the thread Editas Medicine Inc diskutieren
Edit besser als Crispr?
(Laufzeit überschritten)